FGL1 Fc Chimera, Human
| $159.00 | |
| Z03567-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $159.00 | |
| Z03567-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as analyzed by SDS-PAGE | ||||
| Endotoxin Level | < 1 EU/μg of protein by gel clotting method | ||||
| Biological Activity | Immobilized h_LAG3 at 5.0 μg/ml (100 μl/well) can bind FGL1, hFc, Human with a linear range of 0.097–50 μg/ml when detected by Mouse Anti-Human IgG Fc-HRP. | ||||
| Expression System | HEK 293 | ||||
| Apparent Molecular Weight | ~61.8 kDa, on SDS-PAGE under reducing conditions. | ||||
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. | ||||
| Reconstitution | It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O or PBS up to 100 μg/ml. | ||||
| Storage & Stability | Upon receiving, this product remains stable for 6 months at lower than -70°C. Upon reconstitution, the product should be stable for 1 week at 4°C or for 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles. |
»
Immobilized h_LAG3 at 5 μg/ml (100 μl/well) can bind FGL1 Fc Chimera, Human with a linear range of 0.097–50 μg/ml when detected by Mouse Anti-Human IgG Fc-HRP. Background was subtracted from data points before curve fitting. »
| Target Background | FGL1 (Fibrinogen-like protein 1), also known as hepatocyte-derived fibrinogen-related protein 1 (HFREP-1), HP-041, hepassocin (HPS), and liver fibrinogen-related protein 1 (LFIRE-1), is a liver-specific secreted protein belonging to the fibrinogen superfamily whose members share a fibrinogen domain at their C-termini. FGL1 is an immune suppressive molecule that inhibits the activation of antigen-specific T cells by acting as a major ligand of LAG3, and binds LAG3 independently of MHC class II. |
| Synonyms | HFREP-1; HP-041; HPS; LFIRE-1 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.